EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype

Jesús Frutos Díaz-Alejo iD, Iván Prieto-Potín iD, Rebeca Manso iD, Marta Rodríguez iD, Marcos Rebollo-González iD, Francisco Javier Díaz de la Pinta iD, Miriam Morales-Gallego iD, Socorro María Rodríguez-Pinilla, Arantza Onaindia

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125871 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jesús Frutos Díaz-Alejo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM),…. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 349 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence, European Union (FEDER), Recovery and Resilience Mechanism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic Large Cell Lymphoma (ALCL) represents a diverse group of mature T-Cell Lymphomas unified by strong CD30 expression but with different molecular and clinical subtypes. This review summarizes recent molecular advances in ALCL, highlighting key discoveries that have refined its classification, diagnosis, and therapeutic strategies. ALCL comprises four major entities: systemic ALK-positive ALCL, systemic ALK-negative ALCL, Breast Implant-Associated ALCL (BIA-ALCL), and primary cutaneous ALCL. Each subtype exhibits unique phenotypes, along with cytogenetic and molecular alterations that affect clinical outcomes. Nevertheless, different oncogenic mechanisms mediate STAT3 activation. In ALK-positive ALCL, ALK fusion proteins drive oncogenesis via constitutive activation of STAT3 and other signaling pathways. ALK-negative ALCL comprises heterogeneous genetic subtypes, in which JAK/STAT3 pathway alterations and novel gene fusions are gaining recognition as potential therapeutic targets. This review emphasizes the need for integrative molecular diagnostics to improve stratification of ALCL subtypes and targeted treatment approaches. Future research should focus on elucidating the biological mechanisms underlying these alterations and on translating molecular insights into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticHumansImmunophenotypingAnaplastic Lymphoma KinaseSTAT3 Transcription FactorSignal TransductionBiomarkers, Tumor

Stichwörter der Autor:innen

ALKAnaplastic Large Cell LymphomaBIA-ALCLDUSP22STAT3TP63pcALCL

Substanzen

Anaplastic Lymphoma KinaseSTAT3 Transcription FactorBiomarkers, Tumor

Autor:innen und Institutionen

  • Pathology Department, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
  • Pathology Department, Osakidetza Basque Health Service, Araba University Hospital, 01070 Vitoria-Gasteiz, Spain.
  • Oncohaematology Research Group, Bioaraba Health Research Institute, 01070 Vitoria-Gasteiz, Spain.

ORCID-Profile: Jesús Frutos Díaz-Alejo, Iván Prieto-Potín, Rebeca Manso, Marta Rodríguez, Marcos Rebollo-González, Francisco Javier Díaz de la Pinta, Miriam Morales-Gallego

Förderung

  • Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence
  • European Union (FEDER)
  • Recovery and Resilience Mechanism
  • Madrid Autonomous Community
  • Fundación Conchita Rábago (FCR, IIS-FJD) predoctoral scholarship

Zitieren

APA

Frutos Díaz-Alejo, J., Prieto-Potín, I., Manso, R., Rodríguez, M., Rebollo-González, M., Díaz de la Pinta, F. J., Morales-Gallego, M., Rodríguez-Pinilla, S. M., & Onaindia, A. (2025). Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125871

Vancouver

Frutos Díaz-Alejo J, Prieto-Potín I, Manso R, Rodríguez M, Rebollo-González M, Díaz de la Pinta FJ, et al. Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125871

BibTeX
@article{FrutosDazAlejo2025,
  author = {Frutos Díaz-Alejo, Jesús and Prieto-Potín, Iván and Manso, Rebeca and Rodríguez, Marta and Rebollo-González, Marcos and Díaz de la Pinta, Francisco Javier and Morales-Gallego, Miriam and Rodríguez-Pinilla, Socorro María and Onaindia, Arantza},
  title = {Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125871}
}
Kostenlos starten →